Skip to main content

Table 3 Adverse events

From: Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study

Event, n (%)

Venlafaxine (n = 89)

Fluoxetine (n = 93)

P

Nausea

14 (15.7)

11 (11.8)

0.445

Somnolence

6 (6.7)

3 (3.2)

0.274

Dizziness

5 (5.6)

6 (6.5)

0.813

Dry mouth

4 (4.5)

7 (7.5)

0.391

Headache

4 (4.5)

5 (5.4)

0.784

Hand shake

3 (3.4)

2 (2.2)

0.615

Sweating

2 (2.2)

1 (1.1)

0.535

Constipation

2 (2.2)

0

–

Diarrhea

1 (1.1)

3 (3.2)

0.334

Difficulty urinating

1 (1.1)

0

–

Leukopenia

1 (1.1)

0

–

Increased intraocular pressure

0

1 (1.1)

–